IP Library › Granted Patent US 9,023,990
Granted Patent B2
US 9,023,990 · App. 13/206,884 · Granted May 5, 2015

Method for isolating and purifying recombinant human serum albumin from transgenic rice grain

Inventors: Daichang Yang (Hubei, CN); Yang He (Hubei, CN); Guangfei Li (Hubei, CN); Jingru Liu (Hubei, CN)
Assignee: Healthgen Biotechnology Co., Ltd.
C07K14/765
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,023,990
App. No.
13/206,884
Granted
May 5, 2015
Kind
B2
Abstract

A method for separating and purifying recombinant human serum albumin (rHSA) from transgenic rice grain, sequentially comprising the steps of: 1) subjecting crude extract of rHSA to cation exchange chromatography to obtain primary product I; 2) subjecting the primary product I to anion exchange chromatography to obtain secondary product II; 3) subjecting the secondary product II to hydrophobic chromatography to obtain purified rHSA. The method may further comprise a step of ceramic hydroxyapatite chromatography prior to the hydrophobic chromatography. The method has the advantages of low cost and easy operation. The resultant rHSA has a purity of about 99% by HPLC.

Claims (28)

1. A method for isolating and purifying recombinant human serum albumin from transgenic rice grain, sequentially consisting of the steps of:

1) subjecting a crude extract from the transgenic rice grain containing the recombinant human serum albumin to cation exchange chromatography to obtain primary product I;

2) subjecting the primary product I to anion exchange chromatography to obtain secondary product II that contains the recombinant human serum albumin; and

3) subjecting the secondary product II to hydrophobic chromatography to obtain the purified recombinant human serum albumin:

wherein the secondary product II that contains the recombinant human serum albumin to be purified by hydrophobic chromatography further comprises ammonia sulfate at a concentration from 0.1 M to 1 M, and step 3) comprises subjecting the secondary product II to hydrophobic chromatography under a condition that the recombinant human serum albumin does not absorb to the resins of the hydrophobic chromatography and recovering non-adsorbed flow-through fractions to obtain the purified recombinant human serum albumin having a purity of more than 99% (monomer plus dimer and polymer) by HPLC.

2. The method according to claim 1 , wherein the cation exchange chromatography is performed on a chromatography media selected from the group consisting of UNO Sphere S, Capto MMC, Nuvia S and MacroPrep-CM.

3. The method according to claim 2 , wherein the cation exchange chromatography is performed on UNO Sphere S or Capto MMC.

4. The method according to claim 2 , wherein the cation exchange chromatography is performed on UNO Sphere S and employs an elution buffer comprising acetate buffer, 0.25M sodium chloride, with a pH of 5.2.

5. The method according to claim 2 , wherein the cation exchange chromatography is performed on Nuvia S and employs an elution buffer comprising acetate buffer, 0.25M sodium chloride, with a pH of 5.0.

6. The method according to claim 2 , wherein the cation exchange chromatography is performed on Capto MMC, and employs a washing buffer comprising acetate buffer, 1M sodium chloride, with a pH of 4.7 to remove non-target proteins, and an elution buffer comprising acetate buffer, 1M sodium chloride, with a pH of 6.7 to elute the recombinant human serum albumin.

7. The method according to claim 2 , wherein the cation exchange chromatography is performed on MacroPrep-CM, and employs a washing buffer comprising acetate buffer, 1M sodium chloride, with a pH of 4.7 to remove non-target proteins, and an elution buffer comprising acetate buffer, 1M sodium chloride, with a pH of 6.5 to elute the recombinant human serum albumin.

8. The method according to claim 1 , wherein the anion exchange chromatography is performed on a chromatography media selected from the group consisting of Q Sepharose FF, UNO Sphere Q and DEAE sepharose FF.

9. The method according to claim 8 , wherein the anion exchange chromatography is performed on Q Sepharose FF.

10. The method according to claim 8 , wherein the anion exchange chromatography is performed on Q Sepharose FF and employs an elution buffer comprising phosphate buffer, 0.25M sodium chloride, with a pH of 6.0-7.0.

11. The method according to claim 8 , wherein the anion exchange chromatography is performed on DEAE sepharose FF, and employs a washing buffer comprising phosphate buffer, 0.1M sodium chloride with a pH of 6.0-7.0 to remove non-target proteins, and an elution buffer comprising phosphate buffer, 0.25M sodium chloride, with a pH of 6.0-7.0 to elute the recombinant human serum albumin.

12. The method according to claim 1 , wherein the hydrophobic chromatography is performed on a chromatography media selected from the group consisting of Phenyl sepharose HP, Phenyl sepharose FF, macro-prep t-butyl and macro-prep methyl.

13. The method according to claim 12 , wherein the hydrophobic chromatography is performed on Phenyl sepharose HP.

14. The method according to claim 12 , wherein the secondary product II is adjusted to 0.1-1.0 M ammonia sulfate prior to the hydrophobic chromatography step.

15. The method according to claim 12 , wherein the hydrophobic chromatography is performed on Phenyl sepharose HP, and the secondary product II is adjusted to 0.4 M ammonia sulfate prior to the hydrophobic chromatography step.

16. The method according to claim 12 , wherein the hydrophobic chromatography is performed on Phenyl sepharose FF, and the secondary product II is adjusted to 0.1 M ammonia sulfate prior to the hydrophobic chromatography step.

17. The method according to claim 12 , wherein the hydrophobic chromatography is performed on MacroPrep-t-Butyl, and the secondary product II is adjusted to 0.6-1.0 M ammonia sulfate prior to the hydrophobic chromatography step.

18. The method according to claim 1 , wherein said crude extract of the recombinant human serum albumin is prepared by a method comprising the steps of:

i) mixing milled transgenic rice grain containing the recombinant human serum albumin with an extraction buffer in a w/v (kg/L) ratio of 1:5 and extracting at 55-60° C. for 1-1.5 hours to obtain mixture I; said extraction buffer comprising 10-30 mM phosphate buffer, 10-20 mM sodium acetate, 15-30 mM ammonia sulfate and 5-20 mM sodium caprylate, with a pH of 6.5-8;

ii) adjusting the pH of mixture I of step i) to 4.0-4.5 and precipitating it for 3-12 hours to obtain mixture II;

iii) filtrating the mixture II of step ii) and collecting the filtrate to obtain a crude extract containing high concentration of recombinant human serum albumin; said filtrating comprising steps of filtrating by pressure filtration with a filter cloth type plate-frame filter, then filtrating by micro-filtration with a polyethersulfone hollow fiber membrane with a pore size of 0.20 um-0.45 um.

19. The method according to claim 1 , wherein the cation exchange chromatography employs a loading buffer comprising an acetate buffer with a pH less than 5.0.

20. The method according to claim 1 , wherein the cation exchange chromatography employs an elution buffer comprising acetate buffer and sodium chloride, or phosphate buffer and sodium chloride; with a pH of 5.0-6.7.

21. The method according to claim 1 , wherein the purified recombinant human serum albumin has a purity of about 99% (only monomer) by HPLC.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2011
From: YANG, DAICHANG; HE, YANG; LI, GUANGFEI; LIU, JINGRU
To: HEALTHGEN BIOTECHNOLOGY CO., LTD.
Reel/Frame 027108/0377 →
Priority Claims (1)
CN 2010 1 0606635 · Dec 24, 2010 · national
Continuity (1)
Related Publication 20120165509A1 · Jun 28, 2012